Cipla Latest News
The Exchange has sought clarification from Cipla with respect to news article appearing on ET NOW on March 23, 2017 titled ‘USFDA issued import alert on Ciplas Tadalafil drug made at Bhagwanpur unit.’Date:23-03-2017The total consideration of transaction would be ZAR 375 million with potential revision linked to FY2017 performance along with customary adjustmentDate:06-03-2017The company has entered into agreements to divest 100% stake in Cipla Agrimed and Cipla VetDate:06-03-2017
Cipla has informed about a Press Release dated February 17, 2017, titled ‘Cipla launches Hepatitis B vaccine in India’.
The above information is a part of company’s filings submitted to BSE....Date:17-02-2017The company’s strong marketing network and reach will ensure maximum accessibility of the vaccines in IndiaDate:17-02-2017The company’s strong marketing network and reach will ensure maximum accessibility of the vaccines in IndiaDate:17-02-2017Total income of the company increased by 18.09% at Rs 3800.70 crore for the quarter under reviewDate:09-02-2017
Cipla has informed that the Nomination and Remuneration Committee of the Company on February 08, 2017 allotted 39,691 equity shares of Rs 2 each pursuant to exercise of the stock options by the option grantees under Employee St...Date:08-02-2017Four M Propack ceases to be a subsidiary of GoldenCross with effect from February 01, 2017Date:03-02-2017Four M Propack ceases to be a subsidiary of GoldenCross with effect from February 01, 2017Date:02-02-2017